Discrimination of a Her2+ subgroup was not as clear, and they could not identify a significant basal-type group, which would appear to support the IHC studies, suggesting that this phenotype is infrequent in DCIS. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.